Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone-Sensitive Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00422903
What this trial is testing

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 92
Large-scale testing (Phase 3)Active Not RecruitingNCT03324932
What this trial is testing

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

Who this might be right for
Breast Cancer
Kyoto Prefectural University of Medicine 160
Not applicableStudy completedNCT00373191
What this trial is testing

Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Study completedNCT01446159
What this trial is testing

Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer

Who this might be right for
Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
MedImmune LLC 188
Large-scale testing (Phase 3)UnknownNCT00902954
What this trial is testing

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 540
Testing effectiveness (Phase 2)Study completedNCT00240071
What this trial is testing

Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

Who this might be right for
Metastatic Breast Cancer
University of Alabama at Birmingham 30
Not applicableStudy completedNCT00936442
What this trial is testing

Arimidex Therapy Compliance Electronic Monitoring System

Who this might be right for
Breast Cancer
AstraZeneca 104
Testing effectiveness (Phase 2)Study completedNCT00602043
What this trial is testing

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerProgesterone Receptor-negative Breast CancerProgesterone Receptor-positive Breast Cancer+2 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT02760030
What this trial is testing

Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
Estrogen Receptor and/or Progesterone Receptor PositiveHER2/Neu NegativeStage IA Breast Cancer+6 more
Ohio State University Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT06008158
What this trial is testing

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Estrogen Receptor-Positive Breast Carcinoma+1 more
City of Hope Medical Center 48
Testing effectiveness (Phase 2)Ended earlyNCT00461773
What this trial is testing

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer

Who this might be right for
Hormone-Sensitive Breast CancerBreast Cancer
Yale University 5
Not applicableActive Not RecruitingNCT05503160
What this trial is testing

Primary Hormone-sensitive Breast Cancer: Need-driven Health Care Improvement by Patient-centred Digital Application

Who this might be right for
New Healthcare Approach
Technical University of Munich 400
Testing effectiveness (Phase 2)UnknownNCT02690480
What this trial is testing

Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Spanish Breast Cancer Research Group 189
Post-approval studies (Phase 4)Study completedNCT00544986
What this trial is testing

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca
Large-scale testing (Phase 3)Study completedNCT00066690
What this trial is testing

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Carcinoma+5 more
ETOP IBCSG Partners Foundation 3,066
Large-scale testing (Phase 3)Study completedNCT00171704
What this trial is testing

Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Who this might be right for
Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women
Novartis Pharmaceuticals 263
Post-approval studies (Phase 4)Study completedNCT01612871
What this trial is testing

Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer

Who this might be right for
Breast Cancer
Institut Claudius Regaud 39
Testing effectiveness (Phase 2)Study completedNCT00629616
What this trial is testing

Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 116
Post-approval studies (Phase 4)Ended earlyNCT00375752
What this trial is testing

Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer

Who this might be right for
Breast Neoplasms
Novartis Pharmaceuticals 168